Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
about
Linking environmental hazards and birth defects dataEffects and safety of periconceptional oral folate supplementation for preventing birth defectsEffects and safety of periconceptional folate supplementation for preventing birth defectsPrevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, CanadaThe primary prevention of birth defects: Multivitamins or folic acid?Micronutrient deficiencies in pregnancy worldwide: health effects and preventionPreconception care: nutritional risks and interventionsA randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145].Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity.Effect of iron content on the tolerability of prenatal multivitamins in pregnancy.Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands.Periconceptional nutrient intakes and risks of conotruncal heart defectsFolic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST).Socioeconomic measures, orofacial clefts, and conotruncal heart defects in California.International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?Conotruncal heart defects and common variants in maternal and fetal genes in folate, homocysteine, and transsulfuration pathways.Folic acid and orofacial clefts: a review of the evidenceA metabonomic approach to analyze the dexamethasone-induced cleft palate in mice.One-carbon metabolite levels in mid-pregnancy and risks of conotruncal heart defects.Genetic polymorphisms of the TYMS gene are not associated with congenital cardiac septal defects in a Han Chinese populationOral cleft prevention program (OCPP).Bicuspid aortic valve and severe aortic stenosis in a newborn exposed to carbamazapine during pregnancy.Interpretation of controversial teratogenic findings of drugs such as phenobarbital.Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project.Amelia: a multi-center descriptive epidemiologic study in a large dataset from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature.Women's Knowledge, Attitudes and Behavior about Maternal Risk Factors in PregnancyHeart defects and other malformations in the Inuit in Canada: a baseline study.Clinical utility of folate-containing oral contraceptives.Maternal folate, vitamin B12 and homocysteine levels in pregnancies affected by congenital malformations other than neural tube defects.Orofacial clefting: recent insights into a complex traitA preliminary study on the teratogenesis of dexamethasone and the preventive effect of vitamin B12 on murine embryonic palatal shelf fusion in vitro.Maternal hypertension with nifedipine treatment associated with a higher risk for right-sided obstructive defects of the heart: a population-based case-control study.Folic acid in general medicine and dermatology.Elevated body mass index and decreased diet quality among women and risk of birth defects in their offspringWill increasing folic acid in fortified grain products further reduce neural tube defects without causing harm?: consideration of the evidence.Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects.The clinical content of preconception care: genetics and genomics.Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes.Gene promoter DNA methylation patterns have a limited role in orchestrating transcriptional changes in the fetal liver in response to maternal folate depletion during pregnancy.Organ-Specific Gene Expression Changes in the Fetal Liver and Placenta in Response to Maternal Folate Depletion.
P2860
Q23914517-60555414-5D02-4AEE-A1C8-7E691FD5B641Q24187120-C3824E2C-2A74-408C-B2A6-9F73DE85AD0FQ24234551-3055814E-1D4D-44C8-BFD1-093A679816D4Q24644292-713E79A7-3000-4FCB-B4EB-02F3BCA06D57Q24791130-53807698-7C67-4E28-BF06-928B7558F3E6Q26749188-F8D68CEF-83A1-48E7-B243-DF6C95826176Q27022466-F9259398-701D-4AEB-A599-AE611DC1B290Q33238886-A64E92FA-80FF-4C3B-8D3F-1C60BDAB6493Q33306610-BB3D785E-6651-4982-BDA2-9D189D0FC097Q33334978-4A25F92D-94FD-4961-AD20-10F68B290FFDQ33712654-11DBEA58-AD36-416B-B370-964FE3072EECQ33770519-A5D186CE-BCCF-4AF1-8CE1-777739C402DBQ33799905-E13CF7AE-DB25-4306-9C03-EFF5581FC948Q33832015-A4480E74-FF58-4527-878D-8DD698C72E78Q33930503-71FE4CBB-3075-4064-8AA5-967BF23A4024Q33988755-BA25AC07-9832-4079-B931-4D947B7A00EDQ34068983-C81BFD09-52CF-4087-BB15-F367F5AB58D2Q34097466-8C655BF7-CA35-4BBC-BC1E-11486C562BE6Q34142493-E5E08FCF-2D79-4BB3-9A40-18A1DA17DDEFQ34181820-300EC2E7-46ED-4900-955A-D186412E4D86Q34488750-CB3EE62A-9E61-4EB5-9CBE-AA60633B3408Q34843195-3E6DF5AD-3BA6-40FD-9DB3-9EB66A64A2B7Q35195772-FBAF6003-7A6C-41F4-8AAD-8CCB8499A3F8Q35601963-5330AD5D-D969-4CC3-B30E-F19D04B060C5Q35678193-C41E2AC3-6A2C-47CB-A25B-93639C13038DQ35880653-B727CD56-B885-4B4D-BAC8-4235CE824E41Q35939479-65E03217-2953-4E48-B16F-DB1CBBCFEE8FQ35940242-C601CAE3-480D-4BD3-B04B-A52A504A16A2Q36025575-FDB72A5E-3F0B-419C-AC9E-B23CE6D59BEAQ36139769-880E5735-4BE7-42EF-9288-A94B8069E42CQ36513012-05D96F42-953F-4FB0-9BDE-284E2C178A12Q36800874-7D7BF74A-40A3-4D7C-8DED-7B4876A6740CQ36835583-DE2392C2-8FF8-44AE-9CD4-2FD4BAE22B8EQ37013578-40996925-2F1C-47E3-AE58-73BB8E913EDCQ37017005-547A72CA-9E81-4E1E-8A34-456A39347F46Q37025015-BE8DEDB5-42D9-4FAB-9640-0DF35E9AFB7DQ37085696-D8F5862D-489E-4AAC-9526-B0F5BABE8B2EQ37204539-EABAE314-BB06-49FE-BF59-A94C14865463Q37272431-3A8FD62A-E627-42C1-940C-F7B3BE182E83Q37374018-6200617D-7909-4B67-8170-20D0C53BE5C7
P2860
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
@ast
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
@en
type
label
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
@ast
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
@en
prefLabel
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
@ast
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
@en
P2093
P356
P1476
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
@en
P2093
J David Erickson
Lorenzo D Botto
Richard S Olney
P356
10.1002/AJMG.C.30004
P577
2004-02-01T00:00:00Z